AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Dose-Response Relationship, RadiationUltraviolet RaysRadiation InjuriesRadiation OncologyNeoplasmsRadiotherapy DosageRadiation DosageRadiotherapyRadiation, IonizingDose FractionationRadiotherapy, ConformalCombined Modality TherapyMedical IllustrationBrachytherapyRadiation ToleranceRadiotherapy, Intensity-ModulatedCarcinogensRadiotherapy, AdjuvantRadiationCyclic AMP-Dependent Protein Kinase Type IMedical OncologyRadiation ProtectionProstatic NeoplasmsKarnofsky Performance StatusRadiotherapy Planning, Computer-AssistedRadiation MonitoringSurvival AnalysisChemoradiotherapyTreatment OutcomeOrgans at RiskHead and Neck NeoplasmsAndrogen AntagonistsCranial IrradiationSupratentorial NeoplasmsBrain NeoplasmsAneuploidyRadiosurgeryRadiotherapy, High-EnergyCell Transformation, NeoplasticAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingDisease-Free SurvivalCisplatinCarcinoma, Squamous CellNeoplasm Recurrence, LocalChemotherapy, AdjuvantGoserelinLymphatic IrradiationRadiation PneumonitisSurvival RateAmifostinePrognosisNeoplasms, Radiation-InducedRisk AssessmentFollow-Up StudiesRadiometryLung NeoplasmsOncology NursingRetrospective StudiesRadiation Injuries, ExperimentalTumor BurdenRectumFluorouracilCosmic RadiationClinical Trials, Phase III as TopicPelvisGamma RaysAdenocarcinomaAnus NeoplasmsGlioblastomaRisk FactorsRadiation-Sensitizing AgentsProstate-Specific AntigenCarcinoma, Non-Small-Cell LungTime FactorsFlutamideClinical Trials as TopicProportional Hazards ModelsTomography, X-Ray ComputedKaplan-Meier EstimateBackground RadiationDrug Administration ScheduleBreast NeoplasmsRadiation-Protective AgentsRadiotherapy, Computer-AssistedPaclitaxelAntineoplastic Agents, HormonalFeasibility StudiesProspective StudiesParticle AcceleratorsAntineoplastic AgentsRadiodermatitisRadiotherapy, Image-GuidedRadiation EffectsMaximum Tolerated DoseNeoadjuvant TherapyCobalt RadioisotopesTumor Markers, BiologicalMultivariate AnalysisRandomized Controlled Trials as Topic